Clinical trial
Effectiveness and Safety Study of the Continuous Glucose Monitoring System for Home Use (Including In-clinic Sessions) in Patients With Diabetes
NCT04964752 is registered in ClinicalTrials.gov with Lee's Pharmaceutical Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Safety Study of the Continuous Glucose Monitoring System for Home Use (Including In-clinic Sessions) in Patients With Diabetes
- Lead sponsor
- Lee's Pharmaceutical Limited
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 30, 2021
- Completion date
- April 30, 2022
- Enrollment
- 144 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes